Consolidated Statements of Cash Flows (Unaudited) - USD ($)		6 Months Ended
		Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income		$ 8,866,000	$ 12,090,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		17,841,000	17,321,000
Amortization of deferred loan costs		561,000	534,000
Gain on sale of properties		(207,000)	(6,450,000)
Loss on disposal of assets		153,000	72,000
Bad debt		724,000	686,000
Share-based compensation		1,961,000	1,624,000
Deficit in earnings of real estate partnership		0	28,000
Amortization of right-of-use assets - finance leases		60,000	43,000
Changes in operating assets and liabilities:
Escrows and deposits		1,315,000	6,469,000
Accrued rents and accounts receivable		655,000	(1,013,000)
Receivable due from related party		227,000	(19,000)
Unamortized lease commissions, legal fees and loan costs		(1,285,000)	(1,768,000)
Prepaid expenses and other assets		(2,310,000)	999,000
Accounts payable and accrued expenses		(11,723,000)	(7,258,000)
Payable due to related party		(42,000)	0
Tenants' security deposits		121,000	424,000
Net cash provided by operating activities		16,917,000	23,782,000
Cash flows from investing activities:
Acquisitions of real estate		(34,226,000)	(50,136,000)
Acquisitions of real estate - release of restricted cash from 1031 exchange		(10,148,000)	0
Additions to real estate		(10,161,000)	(8,548,000)
Proceeds from sale of property		4,239,000	25,661,000
Net cash used in investing activities		(50,296,000)	(33,023,000)
Cash flows from financing activities:
Distributions paid to common shareholders		(13,690,000)	(12,131,000)
Distributions paid to OP unit holders		(174,000)	(160,000)
Net proceeds from (payments of) credit facility		56,300,000	(11,000,000)
Repayments of notes payable		(17,572,000)	(21,777,000)
Repurchase of common shares		(1,510,000)	(2,641,000)
Payment of finance lease liability		(21,000)	(10,000)
Proceeds from notes payable		0	56,340,000
Payment of loan origination costs		0	(789,000)
Net cash provided by financing activities		23,333,000	7,832,000
Net decrease in cash, cash equivalents and restricted cash		(10,046,000)	(1,409,000)
Cash, cash equivalents and restricted cash at beginning of period		15,370,000	4,640,000
Cash, cash equivalents and restricted cash at end of period (1)	[1]	5,324,000	3,231,000
Supplemental disclosure of cash flow information:
Cash paid for interest		16,522,000	17,013,000
Cash paid for taxes		457,000	432,000
Non cash investing and financing activities:
Disposal of fully depreciated real estate		280,000	45,000
Financed insurance premiums		0	2,638,000
Value of shares issued under dividend reinvestment plan		54,000	42,000
Change in fair value of cash flow hedge		(5,481,000)	5,650,000
Accrued capital expenditures		719,000	1,629,000
Receivable from partnership redemption		0	31,643,000
Recognition of finance lease liability		0	86,000
Recognition of operating lease liability		1,220,000	0
Accrued taxes related to share repurchase		758,000	0
Cash, cash equivalents and restricted cash
Cash and cash equivalents		5,324,000	3,231,000
Restricted cash		0	0
Total cash, cash equivalents and restricted cash		5,324,000	3,231,000
Conversion of OP Units to Common Stock [Member]
Non cash investing and financing activities:
Value of common shares exchanged for OP units		$ 55,000	$ 354,000

[1] For a reconciliation of cash, cash equivalents and restricted cash, see supplemental disclosures below.